Drugs / nDC vaccination
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02993315 | Oct 2016 → Jan 2024 | cutaneous melanoma | Radboud University Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | nDC vaccination | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02993315 ↗ |
| Modality | Cell therapy | “Dendritic cell-based immunotherapy consists of antigen-loaded autologous DC” NCT02993315 ↗ |
| Route | Other | “3 nDC injections intranodally” NCT02993315 ↗ |